Cargando…
Oncolytic Adenoviruses for Cancer Therapy
Many immuno-therapeutic strategies are currently being developed to fight cancer. In this scenario, oncolytic adenoviruses (Onc.Ads) have an interesting role for their peculiar tumor selectivity, safety, and transgene-delivery capability. The major strength of the Onc.Ads is the extraordinary immuno...
Autores principales: | Tripodi, Lorella, Vitale, Maria, Cerullo, Vincenzo, Pastore, Lucio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959120/ https://www.ncbi.nlm.nih.gov/pubmed/33802281 http://dx.doi.org/10.3390/ijms22052517 |
Ejemplares similares
-
Systems Biology Approaches for the Improvement of Oncolytic Virus-Based Immunotherapies
por: Tripodi, Lorella, et al.
Publicado: (2023) -
Bifidobacterium affects antitumor efficacy of oncolytic adenovirus in a mouse model of melanoma
por: Tripodi, Lorella, et al.
Publicado: (2023) -
Combinatorial treatment with oncolytic adenovirus and helper-dependent adenovirus augments adenoviral cancer gene therapy
por: Farzad, Lisa, et al.
Publicado: (2014) -
Oncolytic Adenoviral Vector-Mediated Expression of an Anti-PD-L1-scFv Improves Anti-Tumoral Efficacy in a Melanoma Mouse Model
por: Vitale, Maria, et al.
Publicado: (2022) -
Oncolytic adenoviruses: A potent form of tumor immunovirotherapy
por: Cerullo, Vincenzo, et al.
Publicado: (2012)